Epidarex is a transatlantic venture capital firm that is investing in early-stage start-ups, health technology and high growth life science companies in under-ventured and emerging markets. Epidarex also fund ground-breaking research to help address the huge unmet medical needs in order to provide solutions to benefit patients.
